INTEGRA LIFESCIENCES HOLDINGS CORP - 8-K Filing
Integra LifeSciences priced $450M in senior secured notes due 2033 at a 9.5% interest rate as part of debt refinancing. (Items: 7.01 Regulation FD Disclosure On October 9, 2026, Integra LifeSciences Holdings Corporation (the “Company”) issued a press release announcing the, 9.01 FINANCIAL STATEMENTS AND EXHIBITS (d) Exhibits 99)
Tickers: $IART